Gastric Cancer, Gastroesophageal Junction Cancer Completed Phase Trials for Trastuzumab (DB00072)

IndicationStatusPhase
DBCOND0077587 (Gastric Cancer, Gastroesophageal Junction Cancer)CompletedNot Available
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02731313Human Epidermal Growth Factor Receptor 2 (HER-2) Status in Gastric and Gastro-Esophageal Junction (GEJ) Carcinoma